MARKET

TXMD

TXMD

Therapeuticsmd Inc
NASDAQ
2.090
-0.020
-0.95%
After Hours: 2.050 -0.04 -1.91% 18:58 04/15 EDT
OPEN
2.041
PREV CLOSE
2.110
HIGH
2.190
LOW
2.040
VOLUME
20.15K
TURNOVER
--
52 WEEK HIGH
2.950
52 WEEK LOW
0.9252
MARKET CAP
24.19M
P/E (TTM)
-42.4797
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at TXMD last week (0406-0410)?
Weekly Report · 2d ago
TherapeuticsMD Inc. Stock Rallies 10.0%, Outperforms Market
Dow Jones · 04/06 20:32
Weekly Report: what happened at TXMD last week (0330-0403)?
Weekly Report · 04/06 10:10
TherapeuticsMD Explains Brief Delay In Annual Filing
TipRanks · 04/01 15:39
TherapeuticsMD delays 2025 10-K after filing omits auditor report
Reuters · 04/01 10:08
TherapeuticsMD Narrows 2025 Loss, Advances Royalty Strategy
TipRanks · 03/31 00:12
TherapeuticsMD Q4 EPS $(0.06) Down From $0.01 YoY, Sales $893.000K Up From $667.000K YoY
Benzinga · 03/30 22:10
TherapeuticsMD Inc. Stock Slides 5.2%, Underperforms Market
Dow Jones · 03/30 20:34
More
About TXMD
TherapeuticsMD, Inc. is a pharmaceutical royalty company, which primarily collects royalties from its licensees. It receives royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. It granted a license to commercialize IMVEXXY, BIJUVA, and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands and assigned its exclusive license to commercialize ANNOVERA to Mayne Pharma. IMVEXXY (estradiol vaginal inserts) pharmaceutical product is for the treatment of moderate-to-severe dyspareunia. BIJUVA pharmaceutical product is a Food and Drug Administration (FDA)-approved bioidentical hormone therapy combination of estradiol and progesterone in a single, oral capsule for the treatment of moderate-to-severe vasomotor symptoms due to menopause in women with a uterus. ANNOVERA pharmaceutical product is a one-year ring-shaped contraceptive vaginal system (CVS).

Webull offers TherapeuticsMD Inc stock information, including NASDAQ: TXMD real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TXMD stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading TXMD stock methods without spending real money on the virtual paper trading platform.